Abstract:Neonicotinoids are the most widely used class of insecticides in the United States (U.S.). and the world. Consistent with their high use and persistence, neonicotinoids are often found contaminating drinking water and food. They are also detected in human urine, breast milk, amniotic and cerebrospinal fluids, as well as the brains of treated rodents. Neonicotinoids were once thought to pose little neurotoxic risk to humans, but a growing body of research challenges that assumption. In this study we provide the first comprehensive assessment of unpublished rodent developmental neurotoxicity (DNT) studies on five neonicotinoids that were submitted to the U.S. Environmental Protection Agency (EPA) by neonicotinoid manufacturers. Groups of female rats were administered three different doses of a neonicotinoid during pregnancy and lactation, and their offspring subjected to various neurological tests and brain measurements. We identified nicotine-like effects such as reduced brain size, indicative of neuronal cell loss. Statistically significant shrinkage of brain tissue was observed in high-dose offspring for five neonicotinoids: acetamiprid, clothianidin, imidacloprid, thiacloprid, and thiamethoxam. Two brain regions reduced in the rodent studies-the corpus callosum and caudate-putamen-tend to be smaller in people diagnosed with attention-deficit hyperactivity disorder (ADHD), and in children of mothers who smoked during pregnancy, suggesting a possible link between perinatal neonicotinoid exposure and ADHD. A decreased auditory startle reflex was reported for acetamiprid at all doses and was statistically significant in the mid- and high-dose offspring, and for clothianidin in juvenile high-dose females. No mid- or low-dose brain morphometric data were submitted for acetamiprid, imidacloprid, or thiacloprid. Thiamethoxam mid- and low-dose brain morphometric data were provided to EPA upon request. Only partial mid-dose brain morphometry data were submitted for clothianidin, but no low-dose data. Yet despite this lack of data, EPA concluded that only the high-dose brain morphometric effects were treatment-related-setting the mid-dose as the study's No Observed Adverse Effect Level (NOAEL) or failing to find a definitive NOAEL for acetamiprid, clothianidin, imidacloprid, thiacloprid and thiamethoxam. We found numerous deficiencies in EPA's regulatory oversight and data analyses. EPA dismissed statistically significant adverse effects, accepted substandard DNT studies despite lack of valid positive control data, and allowed neonicotinoid registrants to unduly influence agency decision-making. We conclude that perinatal exposure to neonicotinoids and their metabolites induces adverse, nicotine-like neurotoxic effects in rodent bioassays, and that the exposure limits set by EPA for human exposure are either not protective or not supported by available neurotoxicity data. We propose regulatory changes to empower EPA to better protect public health from developmental neurotoxins like neonicotinoids.

Exposure to neonicotinoids and serum testosterone in men, women, and children

Associations of neonicotinoids with insulin and glucose homeostasis parameters in US adults: NHANES 2015-2016

Variability of Urinary Biomarkers of Neonicotinoid Insecticides in Chinese Population: Implications for Human Exposure Assessment

Neonicotinoid pesticides: evidence of developmental neurotoxicity from regulatory rodent studies

Urinary neonicotinoid concentrations and obesity: A cross-sectional study among Chinese adolescents

Urinary neonicotinoid concentrations and pubertal development in Chinese adolescents: A cross-sectional study

Urinary Neonicotinoids and Metabolites Are Associated with Obesity Risk in Chinese School Children

Associations between neonicotinoid insecticide levels in follicular fluid and serum and reproductive outcomes among women undergoing assisted reproductive technology: An observational study

Urinary neonicotinoid insecticides and adiposity measures among 7-year-old children in northern China: A cross-sectional study

Neonicotinoid Insecticides and Their Characteristic Metabolites may Induce High Fasting Blood Glucose and Obesity in Human

Profiles of neonicotinoid insecticides and characteristic metabolites in paired urine and blood samples: Partitioning between urine and blood and implications for human exposure

Exposure Assessment of Neonicotinoid Insecticides and Their Metabolites in Chinese Women During Pregnancy: A Longitudinal Study

Predictors, sources, and health risk of exposure to neonicotinoids in Chinese school children: A biomonitoring-based study

Urinary Neonicotinoid Insecticides in Children from South China: Concentrations, Profiles and Influencing Factors.

Trends in neonicotinoid pesticide residues in food and water in the United States, 1999–2015

Occurrence and Distribution of Neonicotinoids and Characteristic Metabolites in Paired Urine and Indoor Dust from Young Adults: Implications for Human Exposure.

Sources And Health Risk Of Exposure To Neonicotinoids In Chinese Children: A Biomonitoring-Based Stud

A Nationwide Survey of Urinary Concentrations of Neonicotinoid Insecticides in China.

The Impact of Neonicotinoid Pesticides on Reproductive Health

Exposure levels and health implications of fungicides, neonicotinoid insecticides, triazine herbicides and their associated metabolites in pregnant women and men

Association of Urinary Metabolites of Non-Persistent Pesticides with Serum Sex Hormones among the US Females: NHANES 2013–2014